CRH stock holds as investors await fresh numbers

CRH plc (IE0001827041) remains a large-cap building materials name after reporting FY 2025 revenue of $35.6 billion and adjusted EBITDA of $6.2 billion, a combination that frames how the market has been valuing the shares. The company also reported FY 2025 adjusted earnings per share of $5.29, up 12% from the prior year, according to CRH investor materials on its investor relations page.

FY 2025 earnings set the tone

The FY 2025 numbers matter because they show the scale behind CRH stock: revenue of $35.6 billion, adjusted EBITDA of $6.2 billion, and adjusted EPS of $5.29. The 12% rise in adjusted EPS versus FY 2024 gives investors a concrete comparison point for margin and profit quality.

That profile also makes the company more than a simple construction-cycle proxy. A business that can translate $35.6 billion of annual sales into $6.2 billion of adjusted EBITDA has operating leverage that is visible in the reported figures, not just in market commentary.

Margin still drives the story

CRH said FY 2025 adjusted EBITDA represented a 17.4% margin, based on the $6.2 billion result against $35.6 billion of revenue. That margin gives a cleaner read on the business than revenue alone, especially when investors compare CRH with other building products and materials groups.

The 12% year-on-year increase in adjusted EPS also matters because it ties profit growth to shareholder value more directly than sales growth does. For CRH stock, the market often rewards that mix of size, margin, and earnings progression more than a single quarter headline.

What the product mix shows

CRH's operating model spans cement, aggregates, asphalt, ready-mix concrete, and related building products, with those categories sitting behind the FY 2025 financial results. The company has long used that spread to balance project-led demand and more recurring infrastructure and repair activity.

That mix is important because it helps explain why annual figures such as $35.6 billion in revenue and $6.2 billion in adjusted EBITDA can stay central to the stock story even when day-to-day market noise is limited. Investors usually focus on whether that mix supports another year of earnings growth similar to the 12% FY 2025 increase.

Market value at a glance

CRH stock is trading on the New York Stock Exchange, and the company remains best understood through the combination of its annual financial scale and its margin profile. With FY 2025 revenue at $35.6 billion, adjusted EBITDA at $6.2 billion, and adjusted EPS at $5.29, the latest reported year gives the clearest fixed reference point for valuation work.

As of 21 July 2026, the key takeaway is still the same: CRH is priced around a business that delivered double-digit EPS growth in FY 2025 and maintained a 17.4% adjusted EBITDA margin. Those figures are the most useful public anchors for CRH stock until the next reporting update arrives.